Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Glaxosmithkline (GSK) Share News

IN BRIEF: GSK Chair Jonathan Symonds buys GBP53,000 in shares

6th Feb 2026 16:18

GSK PLC - London-based pharmaceuticals company - GSK Non-Executive Chair Jonathan Symonds buys 2,500 shares, at a price of GBP21.14, worth GBP52,850, on Thursday in London. Read More

LONDON BROKER RATINGS: Oddo BHF cuts Wizz Air and Ryanair

6th Feb 2026 09:37

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and on Thursday: Read More

LONDON MARKET OPEN: FTSE 100 falls as AI fears pressure data stocks

6th Feb 2026 09:15

(Alliance News) - Stock prices in London opened lower on Friday, as renewed fears around artifical intelligence investment spread from the US while software and data stocks came under pressure. Read More

EU regulator greenlights GSK lung disease therapy Nucala

6th Feb 2026 08:37

(Alliance News) - GSK PLC on Friday said the European Commission has approved Nucala, or mepolizumab, as add-on therapy for adults with chronic obstructive pulmonary disease. Read More

LONDON BRIEFING: UK house prices rise more than expected in January

6th Feb 2026 07:55

(Alliance News) - UK house prices rise more sharply than expected, GSK wins approval for Nucala to treat chronic obstructive pulmonary disease in the EU, while Victrex backs its annual guidance. Read More

LONDON MARKET CLOSE: US tech malaise, mining deal flop weigh on FTSE

5th Feb 2026 16:58

(Alliance News) - Stocks in London slumped on Thursday, tracking US and European counterparts, as investors weighed rate calls in Europe and the UK and as merger talks between Glencore and Rio Tinto collapsed once more. Read More

LONDON BROKER RATINGS: Berenberg cuts Fresnillo; Citi cuts Babcock

5th Feb 2026 09:48

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and on Friday: Read More

LONDON MARKET CLOSE: FTSE 100 tops 10,400 as Beazley and Entain soar

4th Feb 2026 17:01

(Alliance News) - The FTSE 100 surged to a fresh high on Wednesday, spurred by strong trading updates and as insurer Beazley said it has accepted a possible GBP8.0 billion bid. Read More

LONDON MARKET MIDDAY: FTSE 100 strengthens as Beazley and GSK rise

4th Feb 2026 12:06

(Alliance News) - Stock prices in London were higher at midday on Wednesday, despite ongoing jitters over the impact of the latest artificial intelligence developments, as Beazley, DCC and GSK helped the FTSE 100 reach a fresh record. Read More

GSK optimistic for 2026 after fourth-quarter results beat forecast

4th Feb 2026 08:54

(Alliance News) - GSK PLC on Wednesday backed guidance after fourth-quarter results beat expectations, driven by growth in its Specialty Medicines and Vaccines divisions and lower-than-expected expenses. Read More

LONDON BRIEFING: Zurich agrees terms for GBP8.0 billion Beazley offer

4th Feb 2026 07:58

(Alliance News) - Beazley agrees to takeover terms for a GBP8.0 billion takeover by Zurich Insurance, while GSK reports "another strong performance" helped by its Specialty Medicines arms. Read More

LONDON MARKET CLOSE: FTSE 100 sets new record despite metals meltdown

2nd Feb 2026 17:02

(Alliance News) - The FTSE 100 shrugged off a weak start, and further volatility in metals and oil prices, to hit new highs on Monday, amid optimism in the manufacturing sector on either side of the pond. Read More

GSK cutting jobs in UK and US as part of ongoing R&D changes

2nd Feb 2026 16:19

(Alliance News) - Drugs firm GSK PLC is axing up to around 350 research and development jobs across the US and UK as part of an ongoing overhaul of the division. Read More

LONDON MARKET CLOSE: Stocks mixed amid tech earnings, Fed fallout

29th Jan 2026 17:06

(Alliance News) - Stock prices in London closed mostly higher on Thursday, as investors digested the US Federal Reserve's Wednesday decision to stand pat on interest rates. Read More

AstraZeneca plots bumper China investment in "exciting next chapter"

29th Jan 2026 10:29

(Alliance News) - Pharmaceutical firm AstraZeneca PLC on Thursday unveiled plans to invest USD15 billion in China through to 2030, in an announcement that coincides with UK Prime Minister Keir Starmer's visit to Beijing. Read More

UK earnings, trading statements calendar - next 7 days

28th Jan 2026 13:01

Read More

LONDON BROKER RATINGS: BofA raises St James's Place and Quilter

27th Jan 2026 09:44

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and on Monday: Read More

LONDON BRIEFING: Sage quarterly revenue up; Dr Martens sales decline

27th Jan 2026 07:59

(Alliance News) - The UK pub sector awaits a GBP100 million support package from the Treasury aimed at easing cost pressures, the Financial Times reports, while Sage posts 10% quarterly revenue growth and Dr Martens reports a dip in third-quarter revenue. Read More

GSK's RSV treatment, Arexvy, secures approval for wider use in EU

26th Jan 2026 08:27

(Alliance News) - GSK PLC on Monday said the European Commission has approved an expanded indication for its respiratory syncytial virus vaccine Arexvy, allowing use in all adults aged 18 and over. Read More

LONDON BRIEFING: GSK wins EU nod for RSV shot; Spire in early talks

26th Jan 2026 07:59

(Alliance News) - GSK wins EU approval to expand use of its RSV vaccine Arexvy to all adults over 18, while Grainger unveils plans for a 195-home West London development, and Impax Environmental Markets outlines its tender offer plan amid continued pressure from activist investor Saba. Read More

FTSE 100 Latest
Value10,369.75
Change60.53